The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator–Treated Patients
Open accessAbstract
Background and Purpose— We sought to investigate the impact of hyperglycemia before reperfusion on long-term outcome in patients treated with intravenous tissue plasminogen activator (tPA). Methods— Of 268 consecutive patients with a nonlacunar middle cerebral artery (MCA) stroke evaluated at <3 hours after onset, 73 (27.2%) received intravenous tPA. Serum glucose was determined at baseline before tPA administration. Hyperglycemia was defined as a glucose level >140 mg/dL. National Institutes of Health Stroke Scale (NIHSS) scores were obtained at baseline and 24 hours. Transcranial Doppler monitoring of recanalization and reocclusion was conducted during the first 24 hours. Total infarct volume was measured on CT at day 5 to 7. Modified Rankin Scale was used to assess outcome at 3 months. Results— Median NIHSS score was 17. At baseline, 31 patients (42.5%) were hyperglycemic and 42 (57.5%) normoglycemic. Early reperfusion (<6 hours) occurred in 43 patients (58.9%). Admission blood glucose correlated negatively with the degree of neurological improvement at 24 hours in reperfused ( r =−0.43; P =0.019) but not in nonreperfused ( r =−0.20; P =0.21) tPA-treated patients. Increased age ( P =0.014), history of diabetes mellitus ( P =0.043), admission glucose >140 mg/dL ( P =0.002), and early reocclusion ( P =0.004) were factors associated with poor outcome among reperfused patients. A logistic regression modeling revealed that only admission glucose value >140 mg/dL (odds ratio, 8.4; 95% CI, 1.76 to 40.02; P =0.005) emerged as an independent predictor of poor outcome despite tPA-induced recanalization. In patients with 6-hour persistent MCA occlusion, baseline NIHSS score >15 points ( P =0.011) and proximal MCA occlusion ( P =0.039) were variables associated with poor outcome on univariate analysis. In a logistic regression model, only NIHSS score >15 points (odds ratio, 11.9; 95% CI, 1.48 to 97.1; P =0.032) remained as an independent predictor of poor outcome and functional dependence at 3 months in nonreperfused tPA-treated patients. Conclusions— Hyperglycemia before reperfusion may in part counterbalance the beneficial effect of early restoration of blood flow, which translates into a worse outcome in hyperglycemic patients despite tPA-induced recanalization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Interobserver agreement for the assessment of handicap in stroke patients
van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988) · Stroke · doi:10.1161/01.str.19.5.604 · Cited by 6,512
Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824
Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.
Lyden, P., Brott, T., Tilley, B., Welch, K. M., Mascha, E. J., Levine, S., Haley, E. C., Grotta, J., & Marler, J. (1994) · Stroke · doi:10.1161/01.str.25.11.2220 · Cited by 1,285
Larrue, V., von Kummer, R., Müller, A., & Bluhmki, E. (2001) · Stroke · doi:10.1161/01.str.32.2.438 · Cited by 1,006
The Stroke Data Bank: design, methods, and baseline characteristics.
Foulkes, M. A., Wolf, P. A., Price, T. R., Mohr, J. P., & Hier, D. B. (1988) · Stroke · doi:10.1161/01.str.19.5.547 · Cited by 946
Malmberg, K., Norhammar, A., Wedel, H., & Rydén, L. (1999) · Circulation · doi:10.1161/01.cir.99.20.2626 · Cited by 847
Moderate hyperglycemia augments ischemic brain damage: A neuropathologic study in the rat
Pulsinelli, W. A., Waldman, S., Rawlinson, D., & Plum, F. (1982) · Neurology · doi:10.1212/wnl.32.11.1239 · Cited by 727
Rezkalla, S. H., & Kloner, R. A. (2002) · Circulation · doi:10.1161/hc0502.102867 · Cited by 621
Cited by
Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management
Kruyt, N. D., Biessels, G. J., DeVries, J. H., & Roos, Y. B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.231 · Cited by 386
Suarez, J. I., Zaidat, O. O., Suri, M. F., Feen, E. S., Lynch, G., Hickman, J., Georgiadis, A., & Selman, W. R. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000146132.29042.4c · Cited by 367
Seners, P., Turc, G., Oppenheim, C., & Baron, J.-C. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308327 · Cited by 334
Nogueira, R. G., Liebeskind, D. S., Sung, G., Duckwiler, G., & Smith, W. S. (2009) · Stroke · doi:10.1161/strokeaha.109.561431 · Cited by 302
Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats
Chen, J., Ye, X., Yan, T., Zhang, C., Yang, X.-P., Cui, X., Cui, Y., Zacharek, A., Roberts, C., Liu, X., et al. (2011) · Stroke · doi:10.1161/strokeaha.111.627174 · Cited by 120
Metadata
- Authors
- Alvarez-Sabín, J., Molina, C. A., Montaner, J., Arenillas, J. F., Huertas, R., Ribo, M., Codina, A., & Quintana, M.
- Venue
- Stroke
- Published
- 2003-05
- Volume
- 34
- Issue
- 5
- Pages
- 1235-1240
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2056469568
- Cited by
- 266
- References
- 42
- FWCI
- 10.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator–Treated Patients. https://app.cochat.ai/papers/10.1161/01.str.0000068406.30514.31
- The paper
- Alvarez-Sabín, J., Molina, C. A., Montaner, J., Arenillas, J. F., Huertas, R., Ribo, M., Codina, A., & Quintana, M. (2003). Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator–Treated Patients. Stroke. https://doi.org/10.1161/01.str.0000068406.30514.31
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.